At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
18F-FDG PET/CTradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Characterization of Radiolabeled Tracer Uptake Pattern in Noninfected Transcatheter Aortic Valves. The COUNT Study. A Prospective, Observational Study.
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec·observational·Posted Sep 25, 2018·Updated Mar 24, 2026
In Brief
An observational study evaluating 18F-FDG PET/CT for Infective Endocarditis. Completed, enrolled 30 participants across 1 site.
Detailed Summary
Therefore, the objective of the study is to characterize the pattern of radiolabeled tracer (18F-FDG) uptake in noninfected transcatheter heart valves in early follow-up after transcatheter aortic valve replacement (TAVR).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInfective Endocarditis
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 2018
Enrollment StartNov 2018
Primary CompletionMar 2022
Study CompletionMar 2025
TodayJul 2026
First PostedSep 25, 2018
Enrollment StartNov 9, 2018
Primary CompletionMar 1, 2022
Study CompletionMar 1, 2025
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 7.8 years ago
Interventions
18F-FDG PET/CTradiation
18F-FDG PET/CT and blood cultures will be performed at 3-month follow-up after TAVR Patients with positive 18F-FDG PET/CT (moderate or intense radiolabeled tracer uptake) will be scheduled for a second 18F-FDG PET/CT at 6-month follow-up.